We usually count superbugs in lives lost. A new study puts a price tag on them instead, and it is a big one: drug-resistant infections were linked to about $3.5 trillion in global economic losses in a single year.
The research was presented at IDWeek 2026, a major infectious diseases meeting in Washington, DC, this week. It was co-led by Dr Hardik Desai of AB Plus Multispecialty Hospital in Ahmedabad and Dr Digantkumar Patel, a hospitalist at Springfield Clinic in Illinois. Their team looked at the year 2021 and found that South Asia, the region that includes India, took the biggest hit in dollar terms.
Quick Facts
- Who: Indian and US researchers led by Dr Hardik Desai and Dr Digantkumar Patel
- What: An estimate of the economic burden of antimicrobial resistance (AMR)
- When: Data for 2021, presented at IDWeek 2026 (October 21–24)
- Where: Global study covering 21 world regions
- Key number: About $3.5 trillion in losses linked to AMR, roughly 2.25% of global GDP
- Directly caused by resistance: $835 billion, about $106 per person worldwide
What the Antimicrobial Resistance Cost Study Found
Antimicrobial resistance happens when bacteria, viruses, fungi or parasites stop responding to the medicines meant to kill them. A urinary infection that once cleared up with a cheap tablet can suddenly need days of hospital treatment, or may not respond at all.
The researchers split their numbers into two buckets, according to CIDRAP, the University of Minnesota’s infectious disease news service:
- Directly attributable: 42.6 million healthy life years (DALYs) lost purely because an infection was drug-resistant, valued at $835 billion.
- Associated: 177.7 million healthy life years lost where a resistant infection played a part, valued at about $3.5 trillion.
Two kinds of illness drove most of the direct losses. Bloodstream infections accounted for $355 billion and lower respiratory infections, such as pneumonia, for $261 billion. Together that is about 74% of the directly attributable figure.
The study also ranked the bacteria behind the damage. Klebsiella pneumoniae topped the list at $130 billion, followed by Streptococcus pneumoniae ($122 billion), Acinetobacter baumannii ($120 billion), E. coli ($117 billion), Staphylococcus aureus ($115 billion) and Pseudomonas aeruginosa ($75 billion). Many of these are familiar names in hospital ICUs.
How the $3.5 Trillion Figure Was Calculated
This is not money that vanished from bank accounts. The team used a method called the “value of lost welfare”, which puts a monetary value on years of healthy life lost to illness, disability or early death. They combined 2021 Global Burden of Disease data with World Bank GDP and population figures, covering 12 types of infection and 22 bacterial pathogens.
Desai told reporters the approach is meant to express human loss in money “so that it can sit next to other spending decisions.” His reasoning was blunt: deaths alone, he said, “don’t move finance ministers.”
In other words, a health minister arguing for more lab equipment or infection control staff now has a number a finance ministry can compare with roads, power plants or subsidies.
South Asia and India: Why This Hits Close to Home
By absolute dollar losses, South Asia came first at $101 billion, ahead of East Asia ($82 billion) and North America ($70 billion), CIDRAP reported. The study coverage does not give a separate figure for India, but India is by far the largest country in the region by population.
Measured as a share of the economy, Africa was hit hardest. Losses equalled 1.42% of GDP in Western sub-Saharan Africa and 0.96% in Eastern sub-Saharan Africa.
Commenting on the study for Healio, Dr Michael Calderwood of Dartmouth Hitchcock Medical Center pointed to unrestricted over-the-counter antibiotic sales in lower-income countries as one driver of resistance. He also flagged resistant bacteria entering the food supply, for example through contaminated, unwashed produce, and noted that resistant infections mean longer hospital stays, lost work and medical debt.
For many Indian families, that last point is the real story. A longer hospital stay is paid for in savings, loans and missed wages long before it shows up in a GDP chart.
The Bigger Picture on Superbugs
The economic estimate sits on top of grim health numbers. The World Health Organization says bacterial AMR was associated with more than 4.7 million deaths worldwide in 2021. Healio, citing earlier research, noted about 1.14 million deaths directly caused by AMR that year, and projections of more than 39 million deaths by 2050.
WHO lists the usual suspects behind the problem: misuse and overuse of antibiotics, poor water and sanitation, weak infection control in homes, hospitals and farms, limited access to vaccines and diagnostics, and too few new antibiotics in development.
The researchers pointed to tools that already exist, CIDRAP reported: pneumococcal conjugate vaccines, infection prevention and control, rapid diagnostics, antibiotic stewardship, and better antibiotic access in poorer countries.
What We Don’t Know Yet
- The findings were presented at a conference. Coverage so far does not say whether a full peer-reviewed paper has been published.
- No India-specific cost figure has been reported from the study.
- The estimate covers 2021 only, so it does not show how costs have moved since.
What This Means for You
You cannot fix a global problem alone, but everyday habits matter because resistance grows every time antibiotics are used when they are not needed. A few simple steps:
- Take antibiotics only when a qualified doctor prescribes them. Most colds, coughs and flu are viral, and antibiotics do nothing for viruses.
- Do not buy antibiotics over the counter or reuse leftover tablets from a past illness.
- Do not share your antibiotics with family members.
- Wash fruits and vegetables well, and keep up with hand hygiene.
- Keep vaccinations up to date, and ask your doctor whether a pneumococcal vaccine is right for you or older relatives.
If you have questions about a specific infection or medicine, consult a doctor.
Our Take
Putting a trillion-dollar label on superbugs may feel cold, but it is a smart move. Health warnings have been loud for years and spending has not kept up. If a number like $101 billion for South Asia gets budget officials to fund labs, nurses trained in infection control and stricter rules on chemist-counter antibiotics, the spreadsheet will have done more than many awareness campaigns.
FAQs
How much does antimicrobial resistance cost the world?
An IDWeek 2026 study linked AMR to about $3.5 trillion in losses in 2021, around 2.25% of global GDP. About $835 billion of that was directly caused by resistant infections.
Which region lost the most money to drug-resistant infections?
South Asia, at $101 billion in direct losses, followed by East Asia ($82 billion) and North America ($70 billion).
Is the $3.5 trillion a direct cash loss?
No. It is a welfare-based value of healthy life years lost, expressed in dollars, not money directly lost from economies.
Which bacteria cause the biggest AMR losses?
Klebsiella pneumoniae led at $130 billion, followed by Streptococcus pneumoniae and Acinetobacter baumannii.
How can I help reduce antibiotic resistance?
Use antibiotics only when a doctor prescribes them, take them exactly as your doctor advises, never self-medicate with leftovers, and keep up with vaccines and hygiene.
Based on reporting by CIDRAP, Healio and the World Health Organization.
Leave a Reply